Dr
Adam
Hines

Partner

York Office

Engineering

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 776 639 2285
Email. [email protected]

Experience

Adam is a commercially-minded attorney with considerable experience of building, optimizing and defending patent portfolios.

Having previously managed an extensive patent portfolio at a multinational healthcare company, Adam is adept at developing harmonized, robust global IP strategies that complement the commercial goals of his clients and add value to their business.

European patent oppositions are a core aspect of Adam’s work. He has a wealth of knowledge in this area having represented clients at over 50 hearings before the European Patent Office both attacking and defending business-critical patents. Adam enjoys the challenging, dynamic and adversarial nature of the opposition process and has an established track record in achieving favourable outcomes for his clients.

Adam is dedicated to providing insightful and pragmatic advice to clients across a range of different industries and specializes in the field of medical technology and medical devices.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Chemistry with Medicinal Chemistry

MSC

Toxicology

PHD

PhD in Biochemistry and Environmental Metabolomics

Publications

Health-conscious IP strategies

View publication online

The Internet of Medical Things

View publication online

Conferences: 2021

November 3rd 2021

Challenging granted patents: a comparison between Europe and the US

Speaker

Event details

June 9th 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

EPO Board of Appeal decision indicates approach to Core AI Inventions

Potential obstacles to obtaining patent protection in Europe for an improvement in a general method for machine learning have been highlighted by a recent decision (T0702/20) from the EPO Board …

Read article

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.